Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is one of the stocks on Jim Cramer’s radar recently. During the lightning round, ...

Now, what are we doing next week?... Tuesday morning starts with the December Consumer Price Index, and it matters.

Medline, Super Micro Computers, Alkermes, Oscar Health, UiPath, Constellation Energy Corp., Smith & Nephew, and more.

Boeing (BA) stock is Jim Cramer's top 2026 pick, up 43% yearly. CEO Ortberg praised as Bernstein raises target to $277 on ...

With bond yields and interest rates expected to remain at historically low levels for as long as the eye can see, the best arena for investors to find income is in the stock market, CNBC's Jim Cramer ...

Buffett has confessed to a fair share of glaring gaffes. The same goes for Jim Cramer. The Mad Money host and author recently ...

On CNBC's “Mad Money Lightning Round,” on Tuesday, Jim Cramer recommended staying away from Dorman Products, Inc. (NASDAQ: DORM). “The only thing worse than housing is cars,” he noted. On the earnings ...

Cramer advises withdrawing money needed within five years from the stock market due to short-term volatility. Investing without understanding the underlying business exposes investors to significant ...

CNBC's Jim Cramer said he's not shocked by the Nasdaq's plunge on Monday, explaining that last week's Bed Bath & Beyond trading frenzy indicated weakness in the index could be on the way. "The next ...

Realty Income (O) offers a 5.61% yield and has paid 664 consecutive monthly dividends. Cramer calls it the go-to stock for retirees seeking consistent income. Johnson & Johnson (JNJ) surged 40% ...

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended selling BP p.l.c. (NYSE: BP). On the earnings front, BP, on Nov. 4, posted third-quarter adjusted earnings of 85 cents per American ...